Home/Filings/4/0001415889-24-008640
4//SEC Filing

Ross Thomas M. 4

Accession 0001415889-24-008640

CIK 0001287098other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 6:21 PM ET

Size

7.7 KB

Accession

0001415889-24-008640

Insider Transaction Report

Form 4
Period: 2024-03-15
Ross Thomas M.
EVP, Global Sales
Transactions
  • Award

    Common Stock

    2024-03-15+25,00025,000 total
  • Award

    Employee Stock Option (right to buy)

    2024-03-15+100,000100,000 total
    Exercise: $4.31Exp: 2034-03-14Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 15, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
  • [F2]Twenty-five percent (25%) of the shares underlying this option shall vest on March 15, 2025, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Issuer

MAXCYTE, INC.

CIK 0001287098

Entity typeother

Related Parties

1
  • filerCIK 0001874572

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 6:21 PM ET
Size
7.7 KB